Downgraded by Cantor-Fitzgerald from hold to sell. Concerned about valuation and quality of earnings. Apparently does not buy the international expansion and vertical integration stories which most of the analysts point to as a reason to buy. I think Cantor has it wrong, but I also think it will be a while before Walgreens clearly demonstrates the growth G. Wassom has predicted. They have time to change their rating again.